These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3301925)
1. Weekly psoriasis therapy using intralesional fluorouracil. Pearlman DL; Youngberg B; Engelhard C J Am Acad Dermatol; 1987 Jul; 17(1):78-82. PubMed ID: 3301925 [TBL] [Abstract][Full Text] [Related]
2. Weekly pulse dosing schedule of fluorouracil: a new topical therapy for psoriasis. Pearlman DL; Youngberg B; Engelhard C J Am Acad Dermatol; 1986 Dec; 15(6):1247-52. PubMed ID: 3543072 [TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of intralesional 5 flurouracil and intralesional triamcinolone acetonide in localized plaque psoriasis. Attwa E; Khater MH; Selim HM; Essam R Dermatol Ther; 2022 Nov; 35(11):e15796. PubMed ID: 36039604 [TBL] [Abstract][Full Text] [Related]
4. Rationally designed combination chemotherapy for the treatment of patients with recalcitrant psoriasis. Alper JC; Wiemann MC; Rueckl FS; McDonald CJ; Calabresi P J Am Acad Dermatol; 1985 Oct; 13(4):567-77. PubMed ID: 2416788 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of keratoacanthoma with intralesional fluorouracil. Goette DK; Odom RB J Am Acad Dermatol; 1980 Mar; 2(3):212-6. PubMed ID: 7364978 [TBL] [Abstract][Full Text] [Related]
6. Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study. de Jong EM; Menke HE; van Praag MC; van De Kerkhof PC Dermatology; 1999; 199(4):313-8. PubMed ID: 10640840 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Sadeghinia A; Sadeghinia S Dermatol Surg; 2012 Jan; 38(1):104-9. PubMed ID: 22093096 [TBL] [Abstract][Full Text] [Related]
14. Intralesional 5-fluorouracil in the treatment of keloids: an open clinical and histopathologic study. Kontochristopoulos G; Stefanaki C; Panagiotopoulos A; Stefanaki K; Argyrakos T; Petridis A; Katsambas A J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):474-9. PubMed ID: 15761426 [TBL] [Abstract][Full Text] [Related]
15. Intradermal fluorouracil and epinephrine injectable gel for treatment of psoriatic plaques. Lowe NJ; Nychay S; Orenberg EK; Korey A Arch Dermatol; 1995 Nov; 131(11):1340-1. PubMed ID: 7503586 [No Abstract] [Full Text] [Related]
16. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. Orenberg EK; Miller BH; Greenway HT; Koperski JA; Lowe N; Rosen T; Brown DM; Inui M; Korey AG; Luck EE J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):723-8. PubMed ID: 1430394 [TBL] [Abstract][Full Text] [Related]
18. Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: interim results of a single-arm, open-label study. Gattu S; Busse K; Bhutani T; Chiang C; Nguyen T; Becker E; Koo JY J Dermatolog Treat; 2012 Apr; 23(2):103-8. PubMed ID: 21254875 [TBL] [Abstract][Full Text] [Related]
19. Etretinate in severe psoriasis. Results of double-blind study and maintenance therapy in pustular psoriasis. Wolska H; Jablonska S; Bounameaux Y J Am Acad Dermatol; 1983 Dec; 9(6):883-9. PubMed ID: 6358282 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial. Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]